Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Toronto Dominion Bank
TD
|
+$471M |
| 2 |
Enbridge
ENB
|
+$330M |
| 3 |
Linde
LIN
|
+$253M |
| 4 |
Scotiabank
BNS
|
+$242M |
| 5 |
Apple
AAPL
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$224M |
| 2 |
PX
Praxair Inc
PX
|
+$191M |
| 3 |
Rogers Communications
RCI
|
+$189M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$181M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$166M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.99% |
| 2 | Energy | 8.06% |
| 3 | Technology | 8.05% |
| 4 | Healthcare | 7.42% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Repligen
RGEN
$9.42B
| $3.48M | ﹤0.01% |
65,996
+4,463
| +7% | +$262K |
|
|
NIE
2227
Virtus Equity & Convertible Income Fund
NIE
$743M
| $3.48M | ﹤0.01% |
187,547
+6,971
| +4% | +$142K |
|
2228
Global X FinTech ETF
FINX
$170M
| $3.48M | ﹤0.01% |
157,315
-11,509
| -7% | -$283K |
|
2229
UDR
UDR
$12.2B
| $3.47M | ﹤0.01% |
87,577
-5,974
| -6% | -$241K |
|
2230
ResMed
RMD
$32.6B
| $3.47M | ﹤0.01% |
30,453
+5,778
| +23% | +$619K |
|
|
AYR
2231
DELISTED
Aircastle Ltd
AYR
| $3.46M | ﹤0.01% |
200,544
+28,121
| +16% | +$535K |
|
|
ESV
2232
PUT
DELISTED
Ensco Rowan plc
ESV
| $3.46M | ﹤0.01% |
+242,725
| New | +$6.26M |
|
2233
First Bancorp
FBNC
$2.74B
| $3.45M | ﹤0.01% |
105,604
-587
| -0.6% | -$21.9K |
|
2234
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$821M
| $3.45M | ﹤0.01% |
162,511
-46,868
| -22% | -$1.09M |
|
2235
Cohen & Steers REIT and Preferred and Income Fund
RNP
$986M
| $3.45M | ﹤0.01% |
193,589
-1,470
| -0.8% | -$26.8K |
|
2236
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$369M
| $3.44M | ﹤0.01% |
124,868
+94,391
| +310% | +$2.79M |
|
|
SPLK
2237
PUT
DELISTED
Splunk Inc
SPLK
| $3.44M | ﹤0.01% |
32,800
| – | – |
|
2238
Merit Medical Systems
MMSI
$5.42B
| $3.43M | ﹤0.01% |
61,490
+58,509
| +1,963% | +$3.48M |
|
2239
CALL
Cameco
CCJ
$42.6B
| $3.43M | ﹤0.01% |
302,000
+100
| +0% | +$1.16K |
|
2240
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.33B
| $3.43M | ﹤0.01% |
336,133
+73,436
| +28% | +$843K |
|
2241
CALL
Goldman Sachs
GS
$303B
| $3.42M | ﹤0.01% |
+20,500
| New | +$4.14M |
|
2242
CALL
Boston Scientific
BSX
$75.1B
| $3.42M | ﹤0.01% |
+96,900
| New | +$3.51M |
|
2243
PUT
Charter Communications
CHTR
$18.4B
| $3.42M | ﹤0.01% |
12,000
-40,000
| -77% | -$12.5M |
|
2244
PIMCO Corporate & Income Opportunity Fund
PTY
$2.49B
| $3.4M | ﹤0.01% |
221,680
+163,648
| +282% | +$2.64M |
|
2245
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.58B
| $3.4M | ﹤0.01% |
202,984
-85,443
| -30% | -$1.66M |
|
2246
Helmerich & Payne
HP
$4.42B
| $3.38M | ﹤0.01% |
70,581
+8,513
| +14% | +$523K |
|
2247
CALL
Thomson Reuters
TRI
$44.9B
| $3.38M | ﹤0.01% |
66,435
-11,118
| -14% | -$596K |
|
|
VVC
2248
DELISTED
Vectren Corporation
VVC
| $3.37M | ﹤0.01% |
46,756
-32,452
| -41% | -$2.33M |
|
|
PRO
2249
DELISTED
PROS Holdings
PRO
| $3.36M | ﹤0.01% |
107,016
+4,791
| +5% | +$152K |
|
2250
BioMarin Pharmaceuticals
BMRN
$13B
| $3.35M | ﹤0.01% |
39,314
+2,512
| +7% | +$239K |
|
Similar funds
Royal Bank of Canada's Q4 2018 Portfolio in Review
As of Q4 2018, Royal Bank of Canada held 7,612 positions worth $208B, down 14% from $241B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Royal Bank of Canada's Q4 2018 filing shows 581 new, 2,367 increased, 3,311 reduced and 633 closed positions. Its largest new stake was Linde: 1,601,713 shares worth $250M. The largest sale was AT&T, an estimated $224M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Energy and Technology.
- Royal Bank of Canada's largest Q4 2018 buy was Linde: 1,601,713 shares worth $250M.
- Royal Bank of Canada added most to Toronto Dominion Bank in Q4 2018, an estimated $471M increase.
- Royal Bank of Canada's biggest Q4 2018 reduction was AT&T, cutting an estimated $224M.
- Royal Bank of Canada fully exited Praxair Inc in Q4 2018, selling an estimated $191M.
- Royal Bank of Canada's ten largest holdings make up 18% of its $208B portfolio in Q4 2018.
- Royal Bank of Canada opened 581 new positions and closed 633 in Q4 2018.
- Royal Bank of Canada's portfolio value fell 14% quarter-over-quarter to $208B.
Based on Royal Bank of Canada's 13F filing for Q4 2018, filed 14 Feb 2019.